Translational Biotechnology Hosted Seminar by Songmao Zheng from Adagene
 |
Accelerate and Boost R&D Success of BioTherapeutics: a Reflection
Songmao Zheng, PhD Wednesday, March 31, 2021 |
||||||||
|
Songmao Zheng is currently Associate Vice President of Research and Development at Adagene https://www.adagene.com, a global clinical-stage cancer immunotherapy company. Prior to his new role, he was Scientific Director/Group Leader leading model-informed drug development for over 60 biologics programs at Janssen BioTherapeutics, Janssen R&D since 2013. He was extensively involved with preclinical, translational and early clinical PK/TE/PD characterization and provided scientific and strategic input for biologics across Oncology, Immunology, Cardiovascular & Metabolic Disease, Infectious Disease and Neuroscience. Songmao obtained his B.S. degree in Biological Sciences from Sichuan University (University of Washington (UW), exchange program) in 2007, then a Ph.D. degree in Pharmaceutical Sciences from UW in 2012, followed by his postdoctoral training at the Center for Pharmacometrics & Systems Pharmacology at the University of Florida. He was an intern at Seattle Genetics in 2010 and an ORISE Fellow at US FDA in 2013. Songmao authored >20 peer-reviewed publications/book chapters and presented in over 30 national and international conferences with 6 conference awards. He is also the co-inventor for 6 Patents.
|
|||||||||
